To meet the logistics needs of today’s pharmaceutical and healthcare customers, it takes a carrier with a strong pharma background. And Swiss WorldCargo is the right carrier to do so. From providing a wide array of sophisticated, temperature controlled container solutions to leveraging the short tarmac times at Zurich airport, Swiss WorldCargo provides the right infrastructure, facilities and solutions to manage the most diverse requirements. 

Various Swiss WorldCargo products offer solutions that meet the wide-ranging needs of our pharmaceutical and healthcare customers. 

  • SWISS °Celsius Active allows for transportation in a wide range of active temperature-controlled containers in temperature ranges from -20 °C to +20 °C. 
  • SWISS °Celsius Passive offers a choice between four official IATA temperature ranges varying between -60°C and +25°C, alongside standardized processes ensuring the proper environment for storage. 
  • SWISS °Celsius Passive Solutions offers standardized processes to ensure that cargo is stored in a required temperature environment. Uninterrupted cool chain door-to-door is also ensured.
Go to article: Home | The dengue dilemma Go to article: In this issueGo to article: Owen MumfordGo to article: ContentsGo to article: Hapa Company Insight Go to article: Daiichi JitsugyoGo to article: NewsGo to article: EmbocapsGo to article: HOF Sonderanlagenbau Company Insight Go to article: HOF SonderanlagenbauGo to article: The pharma industry briefingGo to article: Dow Europe Company InsightGo to article: Gerteis Company InsightGo to article: GerteisGo to article: The problem of manipulated data Go to article: Capsugel Company Insight Go to article: CapsugelGo to article: Timeline: the dengue vaccine dilemmaGo to article: TSS Company Insight Go to article: TSSGo to article: From evergreening to thicketing: exploring manipulation of the pharma patent sysGo to article: Emirates SkyCargoGo to article: AtoZ-CRO Company InsightGo to article: AtoZ-CROGo to article: A safer ride: the latest innovation in targeted cancer treatment Go to article: Swiss WorldCargoGo to article: Accurate BiometricsGo to article: Accurate Biometrics Company Insight Go to article: Nelson LabsGo to article: Treading the line: the challenge of transplant rejection drugsGo to article: Corbion PuracGo to article: Erdmann Design Company InsightGo to article: Erdmann Design SwitzerlandGo to article: Treating menopause: at last a non-hormonal alternative? Go to article: YourwayGo to article: ImmuMap Company Insight Go to article: ImmuMapGo to article: Drug repurposing: the industry’s all-rounder medicinesGo to article: FargoGo to article: Pharma Support Services Company InsightGo to article: Pharma Support ServicesGo to article: One step closer to a Chlamydia vaccine Go to article: AralabGo to article: Synex SyntheticsGo to article: Deals in brief powered by GlobalDataGo to article: Charles Ischi Go to article: The key list powered by GlobalDataGo to article: Pharmaceutical Solutions IndustryGo to article: Clinichain Company Insight Go to article: ClinichainGo to article: SanofiGo to article: EventsGo to article: NymiGo to article: Modality SolutionsGo to article: PfanstiehlGo to article: Next issueGo to article: MimotopesGo to article: ICCI - International Cannabis and Cannabinoids Institute Go to article: ICCI